Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...

Neurocrine Biosciences is a biotechnology company focused on discovering, developing, and marketing treatments for neurological and endocrine-related diseases. The San Diego-based company is best ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

SAN DIEGO, January 13 ... workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

For the latest updates on the LA and San Diego fires, follow USA TODAY's coverage for Wednesday, Jan. 22. SAN DIEGO — Multiple wildfires broke out in San Diego County on Tuesday, prompting ...

Stock Market Value: ~$66.65B ($229.85 per share) Get top local stories in San Diego delivered to you every morning. Sign up for NBC San Diego's News Headlines newsletter. Becton Dickinson (BDX ...

(The Hill) – President Trump indicated Monday he wants a deal for rare earth elements and other items from Ukraine in exchange for continued military aid in the nation’s war against Russia.